Cargando…
Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles
Despite recent advances in targeted therapies and immunotherapies, chemotherapy using cytotoxic agents remains an indispensable modality in cancer treatment. Recently, there has been a growing emphasis in using nanomedicine in cancer chemotherapy, and several nanomedicines have already been used cli...
Autores principales: | Chen, Zhe, Zheng, Yuanqiang, Shi, Yanchun, Cui, Zhengrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768424/ https://www.ncbi.nlm.nih.gov/pubmed/29391792 http://dx.doi.org/10.2147/IJN.S149196 |
Ejemplares similares
-
Oral 4-(N)-stearoyl gemcitabine nanoparticles inhibit tumor growth in mouse models
por: Wang, Caixia, et al.
Publicado: (2017) -
Modified Gold Nanoparticles to Overcome the Chemoresistance to Gemcitabine in Mutant p53 Cancer Cells
por: García-Garrido, Eduardo, et al.
Publicado: (2021) -
Lauric Acid Overcomes Hypoxia-Induced Gemcitabine Chemoresistance in Pancreatic Ductal Adenocarcinoma
por: Takagi, Tadataka, et al.
Publicado: (2023) -
Effect of different lipids and surfactants on formulation of solid lipid nanoparticles incorporating tamoxifen citrate
por: Upadhyay, S. U., et al.
Publicado: (2012) -
Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance—A Mini Review
por: Geisslinger, Franz, et al.
Publicado: (2020)